Quest Diagnostics (DGX) shares climbed about 11% on Thursday after the diagnostic testing company reported second-quarter results that topped Wall Street estimates and lifted its full-year 2026 guidance above consensus.
The company posted adjusted earnings of $3.12 per share, beating To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser